Cytori Therapeutics (CYTX), SST to promote PureGraft System
January 31st, 2011
No comments
Sound Surgical Technologies LLC (SST) has signed a sales agreement for the PureGraft System in the US. Read more…
Archive
Archive for January, 2011
Biotime (AMEX: BTX), Acquisition of Cell Targeting Assets
January 28th, 2011
No comments
BTX has taken over substantially all the assets of Cell Targeting (CTI), Read more…
Categories: BioTime (AMEX:BTX), Stem Cell Research, Stem Cell Technology
UCSD Researchers get $5.6M from CIRM
January 28th, 2011
No comments
University of California, San Diego received $5.6M in grants Read more…
Categories: Stem Cell Research, Stem Cell Technology, UCSD Awards
Athersys (ATHX), Registered Direct Offering of $13.1M
January 28th, 2011
No comments
ATHX to sell 4,366,667 shares of its common stock and warrants Read more…
ReNeuron Group (RENE.L) settles Legal Dispute with Neuralstem (AMEX: CUR)
January 28th, 2011
No comments
RENE.L it has reached a settlement with CUR regarding the existing litigation in the US between the parties. Read more…
Intellectual Property needs to be Secured
January 27th, 2011
No comments
Stem Cell companies survive or fail depending on their clinical trial advancement but, face IP risks far greater than in most other industries. Read more…
Pluristem (PSTI) raising $35.8M in Secondary Offering
January 27th, 2011
No comments
PSTI has priced a public offering of 11M units at a purchase price of $3.25 per unit Read more…
New Culture System for hESCs
January 27th, 2011
No comments
Scientists at UCLA have developed what they claim is a fully chemically defined, animal-free alternative to standard mouse feeder cell-and bovine sera-containing culture systems for human embryonic stem cells (hESCs). Read more…
Categories: Independent Equity Research
Geron (GERN), Essential Thrombocythemia Definition
January 26th, 2011
No comments
Essential thrombocythemia (ET or essential thrombocytosis) is a chronic blood disorder characterized by increased numbers of platelets in the blood. Read more…
Categories: Stem Cell Research, Stem Cell Technology
StemCells (STEM), 2 new Antibody Reagents
January 26th, 2011
No comments
STEM launched STEM24 and STEM133 … 2 antibody reagents that have utility for the isolation and detection of a range of different human cell types. Read more…
Categories: Stem Cell Research, Stem Cell Technology
Henry W. McCusker
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.